登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Template for SAP (interim analysis)
Template for SAP (interim analysis)
收藏
Murdoch Childrens Research Institute
2026-03-15 更新
2026-07-04 收录
临床试验统计分析
中期分析计划
数据链接：
https://mcri.figshare.com/articles/online_resource/Template_for_SAP_interim_analysis_/14741265
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Template to use when writing an interim statistical analysis plan
应用场景：
创建时间：
2021-06-07
相关数据集
Results of comparing treatment groups within visits using linear mixed models and post hoc analysis.
临床试验统计分析
干预效果评估
AAF: standard amino acid formula; AAF-syn: amino acid formula with synbiotic blend. Number of samples: AAF – OM: 16, AAF – 6M: 16, AAF-12M: 16, AAF-syn – 0M: 23, AAF-syn – 6M: 23, AAF-syn – 12M: 22. (
Figshare
2025-09-10 更新
5
0
Analysis of covariance (ANCOVA)* of the difference between the rituximab versus control groups in the distributions of AUC mean values at 12 months of follow-up without and with transformations adjusted for age and sex and the baseline value.
临床试验统计分析
药物疗效评估
*In each analysis, the like-transformed (or untransformed) baseline AUC mean value was employed as an adjusting covariate, e.g. of the baseline value in the analysis of the 12 month values. The means
Figshare
2015-12-02 更新
4
0
mITT and Per protocol analysis at end of treatment.
临床试验统计分析
药效评估
mITT and Per protocol analysis at end of treatment.
NIAID Data Ecosystem
3
0
Results for the two primary outcomes per protocol and intention-to-treat analysis.
临床试验统计分析
Results for the two primary outcomes per protocol and intention-to-treat analysis.
NIAID Data Ecosystem
4
0
Additional file 2 of Assessing non-inferiority for binary matched-pairs data with missing values: a powerful and flexible GEE approach based on the risk difference
非劣效性试验
临床试验统计分析
Supplementary Material 2.
Figshare
2025-02-28 更新
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
